Navigation Links
European Multidisciplinary Conference on Thoracic Oncology

The European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS) are pleased to announce the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO).

This meeting will provide a comprehensive update and a multidisciplinary perspective of state-of-the-art on the prevention, screening, diagnosis, and treatment of chest tumors, including results of translational research. It will facilitate scientific and clinical exchange, with the aim of promoting an integrated approach to diagnosis, treatment and management of thoracic cancers.

Thoracic cancers are globally recognized as a major cause of mortality. Combating their causes, developing better methods for early detection, advancing research, and improving treatments, require the collaboration of many research and clinical specialties.

Organized in partnership between the European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS), the conference is designed to provide healthcare professionals with a comprehensive update and a multidisciplinary perspective of state-of-the-art management of patients with thoracic malignancies, including the role of new technologies and the necessary collaboration between various medical specialties.

By bringing together authoritative European partners in thoracic oncology, EMCTO represents an excellent opportunity to promote an integrated approach to diagnosis and treatment of chest tumors and to strengthen European cooperation and scientific exchange .

Meeting highlights:

  • New developments in understanding lung cancer biology
  • Prognostic and predictive factors in non-small-cell lung cancer
  • Critical appraisal of imaging tools in thoracic oncology
  • Individualized staging: practical implications
  • Heterogeneity of locally advanced lung cancer and its implications for treatment
  • Chemoradiotherapy and new developments in radiotherapy
  • Neuroendocrine tumors, mesothelioma and thymoma
  • Individualized therapy based on tumor features
  • Elderly and co-morbid patients
  • Future developments in multidisciplinary treatments

Among the top international experts who have contributed to this multidisciplinary conference: Rolf Stahel, Switzerland; Robert Pirker, Austria; David Gandara, US; Enriqueta Felip, Spain; Giorgio Scagliotti, Italy; Franoise Mornex, France; Paris Kosmidis, Greece; Michael Cullen, UK; Jean-Paul Sculier, Belgium; Cesare Gridelli, Italy; Walter Weder, Switzerland

Meeting venue

The European Multidisciplinary Conference in Thoracic Oncology (EMCTO) will take place at the Palazzo dei Congressi, Lugano.

Services for media representatives

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. You will have access to all the scientific sessions and the possibility to schedule one-on-one interviews with top speakers and presenters of the studies, both in presence and remotely. Please contact the ESMO Communication Dept. at to already find out about the preliminary timetable or to book a telephone hook up. The conference full program is available at

Media registration

To register for the conference as a media representative, please visit and send the Complimentary Media Registration form to the ESMO Communication Department.


For hotel reservation, please visit:

Contact: ESMO Press Office
European Society for Medical Oncology

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: